COMMUNIQUÉS West-GlobeNewswire

Hemp Hop Launches 93% THCa Concentrate + 2 Exotic THCa Flowers
20/08/2025
CHARLOTTE, N.C., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Hemp Hop , a trusted name in premium hemp products since 2018, has just launched its latest lineup — 3 fresh THCa concentrate dabs and 2 exotic THCa flower strains. [...]
Autonomix Medical, Inc. Granted New European Patent for First-in-Class Catheter-Based Technology
20/08/2025
Global patent estate encompasses 80 issued patents and 40 pending patent applications Strengthens strategic position in a multi-billion-dollar market opportunity across cardiovascular, renal, and other high-burden [...]
Adial Pharmaceuticals Encouraged By U.S. Senate Support for Expanded Clinical Trial Endpoints Beyond Abstinence in Alcohol and Substance Use Disorder Treatments
20/08/2025
U.S. Senate Appropriations Report Further Validates Adial’s Therapeutic Approach and Promotes a More Contemporary Patient Focused Regulatory Environment GLEN ALLEN, Va., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Adial [...]
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Ramón Polo as Senior Vice President, Head of Global Regulatory Affairs
20/08/2025
SOUTH SAN FRANCISCO, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies [...]
Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications
20/08/2025
With the Newly Granted IP, the Company’s IP Portfolio for the LIBERTY ® System now includes 12 patents granted globally and 57 patent applications pending. The Company Continues to Scale Commercial Readiness Plans for [...]
Vivani Medical CEO Adam Mendelsohn to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025
20/08/2025
ALAMEDA, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. ( NASDAQ: VANI ) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, [...]
Dror Ortho-Design Launches Global ZSmile Innovation Network Initiative to Transform the Stagnating Aligner Market
20/08/2025
JERUSALEM, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Dror Ortho-Design, Inc. (OTC PINK: DROR), a pioneer in AI-powered orthodontic solutions, today announced the launch of the ZSmile Innovation Network, a global community of [...]
Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share
20/08/2025
WALTHAM, Mass., DUBLIN, Ireland and EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company (“ Mural ”), and XOMA Royalty Corporation (Nasdaq: [...]
Easy Environmental Solutions Launches Terreplenish Trials in Tanzania, Opening Door to Multi-Unit Deployment
20/08/2025
MANKATO, Minn., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Digital Utilities Ventures, Inc. (OTC: DUTV), operating as Easy Environmental Solutions Inc., today announced a strategic collaboration with the Tanzania Fertilizer [...]
Earth Science Tech, Inc. Boosts Share Repurchase Program to $10 Million and Extends Authorization Through 2027
20/08/2025
Miami, Fla., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential businesses, today announced its [...]
Option Care Health Announces Chief Financial Officer Transition
20/08/2025
Mike Shapiro to Step Down After 10 Years With the Company; Meenal Sethna Named EVP and CFO Effective October 1, 2025 BANNOCKBURN, Ill., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “ [...]
Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share
20/08/2025
WALTHAM, Mass. and DUBLIN and EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company (“ Mural ”), and XOMA Royalty Corporation (Nasdaq: XOMA), a [...]
Femasys Secures UK Regulatory Approval of FemBloc Permanent Birth Control
20/08/2025
--Advances European commercialization strategy following CE mark approval-- ATLANTA, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical [...]
Eleos Launches AI Scanner to Navigate Medicaid Eligibility Risk in Real Time
20/08/2025
The new OBBBA AI scanner uses Eleos’ ambient AI technology to alert providers of patient eligibility changes, preserving revenue and ensuring care continuity amid sweeping Medicaid policy changes BOSTON, Aug. 20, 2025 ( [...]
Regulatory Approval Granted for Commencement of Trinity Biotech’s Offshored and Outsourced Manufacturing of its Flagship Rapid HIV Test, Facilitating Strategic and Financial Performance Transformation
20/08/2025
Approval Facilitates Immediate Offshored and Outsourced Manufacturing Strategic Offshore Manufacturing Move Expected to Drive Gross Margin Expansion, Free Up Working Capital, and Enhance Scalability Transition to [...]
Longeveron® to Present at the H.C. Wainwright 27th Annual Global Investment Conference
20/08/2025
MIAMI, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging- [...]
Calidi Biotherapeutics Announces Pricing of $6 Million Underwritten Public Offering
20/08/2025
SAN DIEGO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of targeted therapies with [...]
Noble Capital Markets Initiates Equity Research Coverage on Greenwich LifeSciences
20/08/2025
STAFFORD, Texas, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is [...]
Novo Nordisk to present Wegovy® and Ozempic® data showing life-saving cardiovascular benefits for people living with obesity and type 2 diabetes at the European Society of Cardiology Congress 2025
20/08/2025
Data to highlight the impact of Wegovy ® (semaglutide 2.4 mg) on atrial fibrillation – a common heart rhythm condition – in people living with obesity (SELECT study) Additional Rybelsus ® and Ozempic ® data demonstrate [...]

Pages